Guibin Qiao

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen et al. · Journal of Clinical Oncology · 2019 · 267 citations

Medicine, Oncology, Pharmacology +15

Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

Qiang Gao, Binrong Li, G.Q. Wang et al. · Annals of Oncology · 2023 · 117 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

Wen‐Zhao Zhong, Hong‐Hong Yan, Ke‐Neng Chen et al. · Signal Transduction and Targeted Therapy · 2023 · 77 citations · Full text

Medicine, Oncology, Pharmacology +14

Serologic Association Between Human Papillomavirus Type 16 Infection and Esophageal Cancer in Shaanxi Province, China

Cheng Han, Guibin Qiao, N L Hubbert et al. · JNCI Journal of the National Cancer Institute · 1996 · 70 citations

Medicine, Microbiology, Oncology +13

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

Guibin Qiao, Weitao Zhuang, Bo Dong et al. · BMC Medicine · 2021 · 57 citations · Full text

Medicine, Molecular Biology, Oncology +17